December 9, 2025

CG Oncology, Inc. (CGON) Stock Analysis: Exploring a 65% Potential Upside in the Biotech Sector

Investors with a keen eye on the biotechnology sector should take a closer look at CG Oncology, Inc. (CGON), a prominent player in the healthcare industry focused on groundbreaking bladder..

Brookdale Senior Living Inc. (BKD) Investor Outlook: Navigating the Healthcare Giant’s 8.16% Potential Upside

Brookdale Senior Living Inc. (NYSE: BKD), a key player in the U.S. healthcare sector, operates within the medical care facilities industry. With a market capitalization of $2.54 billion, the company..

Galapagos NV (GLPG) Stock Analysis: Navigating the Biotech Landscape Amidst High Valuation

Investors with a keen eye on the biotechnology sector might find Galapagos NV (NASDAQ: GLPG) an intriguing study in contrasts. With a market capitalization of $2.11 billion, this Belgian company..

Phreesia, Inc. (PHR)

⚠️ No article content returned.

..

Pulse Biosciences, Inc (PLSE) Stock Analysis: Exploring a 63% Upside Potential in the Innovative Bioelectric Medicine Space

As investors seek opportunities in the ever-evolving healthcare sector, Pulse Biosciences, Inc (NASDAQ: PLSE) emerges as a captivating prospect, especially with a potential upside of 63.08%. Specializing in the burgeoning..

Astrana Health Inc. (ASTH) Stock Analysis: Potential 82.95% Upside as Revenue Nears 100% Growth

Astrana Health Inc. (NASDAQ: ASTH) is capturing the attention of investors with its remarkable revenue growth and substantial upside potential. Founded in 1994, the Alhambra, California-based company, formerly known as..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: A Healthcare Innovator with 14% Upside Potential

Alphatec Holdings, Inc. (NASDAQ: ATEC), a pioneering force in the healthcare sector, is capturing investor attention with its strong potential for growth. Specializing in medical devices, this Carlsbad, California-based company..

MannKind Corporation (MNKD) Stock Analysis: Potential Upside of 66.77% Captivates Investors

MannKind Corporation (NASDAQ: MNKD), a pioneering biopharmaceutical company, is becoming a focal point for investors seeking promising opportunities in the healthcare sector. With its dedication to developing innovative therapies for..

Protagonist Therapeutics, Inc. (PTGX) Investor Outlook: Strong Buy Ratings Highlight Promising Growth in Biotech

Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a biopharmaceutical company focused on innovative peptide therapeutics, has captured the attention of investors with its promising pipeline and strong analyst endorsements. Specializing in treatments..

Ocular Therapeutix, Inc. (OCUL): Investor Outlook Reveals 47% Potential Upside

Ocular Therapeutix, Inc. (NASDAQ: OCUL) has caught the eye of investors with its promising potential upside of 47.42%, according to recent analyst ratings. As a biopharmaceutical company focused on innovative..

AdaptHealth Corp. (AHCO): Investor Outlook Reveals 41% Potential Upside in Healthcare Sector

AdaptHealth Corp. (NASDAQ: AHCO), a key player in the medical devices industry, presents a compelling investment opportunity with a projected upside of over 41%. Specializing in home medical equipment and..

Celldex Therapeutics (CLDX) Investor Outlook: A Biotech Stock with a Promising 78% Upside

Celldex Therapeutics, Inc. (NASDAQ: CLDX) stands at the forefront of the biotechnology sector, capturing investor attention with its cutting-edge research and promising drug candidates. As a biopharmaceutical company, Celldex is..

Mesoblast Limited (MESO) Stock Analysis: Eye-Catching Potential Upside for Biotechnology Investors

Mesoblast Limited (NASDAQ: MESO), an innovative leader in regenerative medicine, is capturing investor attention with a striking potential upside of 93.26%. Specializing in cutting-edge biotechnology, Mesoblast harnesses the power of..

Opko Health, Inc. (OPK) Stock Analysis: Exploring a 169.57% Potential Upside in Healthcare Innovation

Opko Health, Inc. (NASDAQ: OPK) operates at the intersection of diagnostics and pharmaceuticals, delivering a diverse range of healthcare solutions across the United States and internationally. With a market capitalization..

Apogee Therapeutics, Inc. (APGE) Stock Analysis: High Potential Upside with 12 Buy Ratings

Apogee Therapeutics, Inc. (NASDAQ: APGE), a burgeoning player in the biotechnology sector, has quickly attracted investor attention due to its strategic focus on developing novel biologics targeting a range of..

ANI Pharmaceuticals (ANIP) Stock Analysis: Evaluating a Potential 33.73% Upside

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), a prominent player in the healthcare sector, is capturing investor attention with its promising potential upside of 33.73%. Specializing in both branded and generic pharmaceutical..

10x Genomics, Inc. (TXG) Stock Analysis: Evaluating the Growth Potential Amidst a Challenging Market Landscape

As the healthcare sector continues to evolve, 10x Genomics, Inc. (NASDAQ: TXG) stands out with its cutting-edge life science technology aimed at revolutionizing the analysis of biological systems. Despite a..

Premier, Inc. (PINC) Stock Analysis: A Steady Dividend Payout Amidst Revenue Challenges

Premier, Inc. (NASDAQ: PINC), a key player in the healthcare sector, primarily operates within the health information services industry. The company, headquartered in Charlotte, North Carolina, has established itself as..

Integra LifeSciences Holdings C (IART) Stock Analysis: Navigating a 19% Potential Upside in the Medical Devices Sector

Integra LifeSciences Holdings Corporation (NASDAQ: IART) operates at the intersection of innovation and healthcare, providing a wide array of medical devices aimed at improving surgical outcomes and patient care. With..

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Exploring a 62% Upside Potential

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) has emerged as a compelling player in the biotechnology sector, particularly for investors seeking exposure to innovative treatments for muscle disorders. With a market capitalization..

Search

Funds

December 9, 2025

Search

Funds

December 9, 2025

FTSE 100

Funds